✦ LIBER ✦

582 CMF versus CMF + tamoxifen in advanced breast cancer. Final analysis of a randomized eortc study

✍ Scribed by H.T. Mouridsen; C. Rose; E. Engelsnan; R. Sylvester

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cmf versus cmf + tamoxifen in advanced b

✍ H.T. Mouridsen; C. Rose; E. Engelsman 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Combined cytotoxic and endocrine therapy

✍ H.T. Mouridsen; C. Rose; E. Engelsmann; R. Sylvester; N. Rotmensz 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 581 KB

Combined cytotoxic and endocrine therapy

✍ Mouridsen, H.T; Rose, C; Engelsman, E; Sylvester, R; Rotmensz, N 📂 Article 📅 1985 🏛 Elsevier Science ⚖ 954 KB

Tamoxifen plus sequential CMF chemothera

✍ John H. Glick; Richard H. Creech; Susan Torri; Christopher Holroyde; Harvey Brod 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 631 KB

Randomized clinical trial of tamoxifen p

✍ John H. Glick; Richard H. Creech; Susan Torri; Christopher Holroyde; Harvey Brod 📂 Article 📅 1981 🏛 Springer US 🌐 English ⚖ 914 KB

“Classical” CMF versus a 3-weekly intrav

✍ E. Engelsman; J.C.M. Klijn; R.D. Rubens; J. Wildiers; L.V.A.M. Beex; M.A. Nooij; 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 543 KB